Effect of Ketoconazole On Pharmacokinetics of Tivozanib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor

被引：1
|
作者：
Cotreau, M. [1 ]
Siebers, N.
Massmanian, L. [1 ]
Strahs, A. [1 ]
Vargo, D. [1 ]
机构：
[1] AVEO Oncol, Clin Pharmacol, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72392-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
595
引用
下载
收藏
页码：182 / 183
页数：2
相关论文
共 50 条
  • [1] Effects of Ketoconazole or Rifampin on the Pharmacokinetics of Tivozanib Hydrochloride, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
    Cotreau, Monette M.
    Siebers, Nicholas M.
    Miller, James
    Strahs, Andrew L.
    Slichenmyer, William
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (02): : 137 - 142
  • [2] The Effect of Rifampin On the Pharmacokinetics of Tivozanib, a Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor
    Cotreau, M.
    Subic, D.
    Massmanian, L.
    Strahs, A.
    Vargo, D.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 183 - 183
  • [3] Effect of cediranib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, in a mouse model of choroidal neovascularization
    Kang, Seungbum
    Park, Ki Cheol
    Yang, Keum-Jin
    Choi, Hyun-Su
    Kim, So-Hee
    Roh, Young-Jung
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 (01): : 63 - 72
  • [4] Pharmacokinetics, Metabolism, and Excretion of [14C]Axitinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Humans
    Smith, Bill J.
    Pithavala, Yazdi
    Bu, Hai-Zhi
    Kang, Ping
    Hee, Brian
    Deese, Alan J.
    Pool, William F.
    Klamerus, Karen J.
    Wu, Ellen Y.
    Dalvie, Deepak K.
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (05) : 918 - 931
  • [5] Acquired Drug Resistance to Vascular Endothelial Growth Factor Receptor 2 Tyrosine Kinase Inhibitor in Human Vascular Endothelial Cells
    Arao, Tokuzo
    Matsumoto, Kazuko
    Furuta, Kazuyuki
    Kudo, Kanae
    Kaneda, Hiroyasu
    Nagai, Tomoyuki
    Sakai, Kazuko
    Fujita, Yoshihiko
    Tamura, Daisuke
    Aomatsu, Keiichi
    Koizumi, Fumiaki
    Nishio, Kazuto
    ANTICANCER RESEARCH, 2011, 31 (09) : 2787 - 2796
  • [6] Neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Roy, Bhaskar
    Das, Avash
    Ashish, Kumar
    Bandyopadhyay, Dhrubajyoti
    Maiti, Abhishek
    Chakraborty, Sandipan
    Stone, Martha E.
    Philpotts, Lisa Liang
    Nowak, Richard J.
    Patwa, Huned S.
    NEUROLOGY, 2019, 93 (02) : E143 - E148
  • [7] Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Ghatalia, Pooja
    Morgan, Charity J.
    Choueiri, Toni K.
    Rocha, Pedro
    Naik, Gurudatta
    Sonpavde, Guru
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (01) : 136 - 145
  • [8] The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases
    Anthony El-Khoueiry
    James A. Posey
    Juan Ramón Castillo Ferrando
    Smitha S. Krishnamurthi
    Shariq Syed
    Georgia Kollia
    Ian Walters
    Bruce S. Fischer
    Eric Masson
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 53 - 64
  • [9] The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases
    El-Khoueiry, Anthony
    Posey, James A.
    Castillo Ferrando, Juan Ramon
    Krishnamurthi, Smitha S.
    Syed, Shariq
    Kollia, Georgia
    Walters, Ian
    Fischer, Bruce S.
    Masson, Eric
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 53 - 64
  • [10] Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
    Ghatalia, Pooja
    Morgan, Charity
    Choueiri, Toni K.
    Rocha, Pedro
    Naik, Gurudatta
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345